Europe Mammography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Europe Mammography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Europe Mammography Market is poised to grow at a CAGR of 5.4% over the forecast period.

COVID-19 has impacted the mammography market during the pandemic as many hospitals and screening centers were shut down due to a lockdown scenario. For instance, as per a study published in June 2022, titled ‘Impact of the COVID-19 pandemic on breast cancer screening indicators in a Spanish population-based program: a cohort study’, it has been observed that covid-19 has negatively affected the breast cancer screening attendance, especially in previous participants and newcomers. This has impacted the market growth. However, with the released COVID-19 restrictions and resumed screening services, the hospital and clinic visits for screening breast cancer have increased which is anticipated to propel the market growth over the forecast period.

Certain factors that are propelling the market growth are the increasing prevalence of breast cancer, technological advancements in the field of breast imaging, and increasing initiatives to create awareness regarding breast cancer screening.

Breast cancer is one of the major prevalent forms of cancer in Europe and the growing burden signifies that there is a high need for proper treatment and screening to detect breast cancer hence the market is likely to grow during the forecast period. For instance, as per the Joint Research Commission’s report of the European Commission released in July 2020, it was estimated that in 2020, breast cancer was the most diagnosed cancer in Europe. More than 355,000 women in the European Union (EU-27) were diagnosed with breast cancer in 2020, which was about 13.3% of all cancer diagnoses.

Also, according to 2021 statistics published by Breast Cancer Now, it has been observed that about 55,000 women are diagnosed with breast cancer in the United Kingdom, every year. As per the same source, 46,000 people are diagnosed with breast cancer in England every year, followed by 4,700 in Scotland, 2,800 in Wales, and 1,500 in Northern Ireland. Thus, the high burden of breast cancer cases raises the need to early detect breast cancer which is expected to propel the market for mammography over the forecast period.

Additionally, the rising awareness regarding breast cancer and timely screening among the population is also expected to boost market growth over the forecast period. For instance, as per a news published in October 2021, a breast cancer awareness campaign, ‘Breast Cancer Affects Us All’, was created by Wefra Life and the non-profit association Pink Ribbon Germany, to raise awareness about breast cancer, creating a sense of community around the issue, and promoting breast care, a free multilingual app that covers all relevant aspects of early breast cancer detection and prevention in the multimedia form in seven different languages. Also, in July 2021, Federación Española de Cancer de Mama (FECMA) organized a campaign to raise awareness about the types of breast cancer, the need of breast cancer patients, and advocate for them.

Furthermore, various companies are currently involved in augmenting breast screening programs in Germany, along with undertaking several strategic alliances, such as partnerships and acquisitions for increasing their market share within the country. For instance, recently in July 2021, GE Healthcare Germany provided a mammography mobile unit for screening breast cancer patients. The unit was manufactured within three months for private radiology practice, along with training the users as well as mammography equipment calibration. Also, many major tech companies are using AI (artificial intelligence) models that can automatically detect breast cancer. For instance, in June 2020, Vara, a Berlin-based company raised EUR 6.5 million in Series A funding for AI-powered breast cancer screening software. Moreover, in May 2021, Roche Italia and Fujifilm Italia collaborated with the Italian National Health Services to reprioritize breast health with the screening routine campaign. This collaboration included the replacement of obsolete equipment with a focus on the ratio between analog and digital machines in each region in Italy. These programs and technological advancements associated with mammograms are expected to boost market growth.

However, the high cost and poor reimbursement scenarios as well as risks of adverse effects from radiation exposures are some of the factors that are hindering the market growth over the forecast period.

Key Market TrendsDigital Systems Segment Expects to Register a High CAGR in the Europe Mammography Market Over the Forecast Period

The digital system segment is expected to witness significant growth in the mammography market in Europe over the forecast period owing to the factors such as the rising technological advancement and increasing incidences of breast cancer in Europe. In addition, with the advent of digital mammography, an increasing number of countries are experiencing shifts toward these newer systems, due to their superior depiction of low-contrast objects, wider dynamic change, and improved diagnostic quality of images, especially when examining denser breasts.

People with breast cancer are more likely to contract infections, and numerous organizations have taken significant steps to control these diseases. For instance, in September 2020, the European Society for Medical Oncology (ESMO), the Spanish Society of Radiation Oncology (SEO), and the Spanish Society of Medical Oncology (SEOM) published some recommendations on how to modify treatment protocols to minimize risks in breast cancer patients. The updated recommendations offer more effective techniques for performing procedures, which would benefit the therapies.

Furthermore, the rising product launches in the region are also contributing to the growth of the segment. For instance, in April 2021, Fujifilm Europe GmbH launched the ‘Harmony’ version of its Amulet Innovality mammography system in Germany. AMULET Innovality is a Full Field Digital Mammography (FFDM) equipped with Fujifilm’s unique and innovative technologies that achieve optimum image quality at a very low patient dose. Also, in October 2020, Hologic, Inc. launched an artificial intelligence-powered 3DQuorum Imaging Technology in Europe.

Thus, owing to the aforementioned factors, the studied market is expected to grow over the forecast period.

Competitive Landscape

The mammography market is a consolidated one, owing to the presence of a few major players in the market. The European market is competitive players due to the presence of almost all the global players in the Mammography market. Many of these global players have there headquarters in European countries, which increases the accessibility of Mammography devices throughout the Europe.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.